Arena Capital Advisors, LLC- CA - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 51 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Arena Capital Advisors, LLC- CA ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$57,742
+1.3%
5,7170.0%0.03%
+88.2%
Q3 2022$57,000
+1.8%
5,7170.0%0.02%
+21.4%
Q2 2022$56,000
-94.5%
5,717
-94.5%
0.01%
-90.9%
Q1 2022$1,013,000
-65.3%
103,742
-65.5%
0.15%
-42.8%
Q4 2021$2,919,000
-0.3%
300,8990.0%0.27%
+16.5%
Q3 2021$2,928,000
+300.5%
300,899
+301.2%
0.23%
+278.7%
Q2 2021$731,00075,0000.06%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Exos Asset Management LLC 45,300$441,0000.23%
MMCAP International Inc. SPC 250,000$2,435,0000.12%
Atalaya Capital Management LP 40,000$386,0000.10%
Radcliffe Capital Management, L.P. 200,000$1,942,0000.06%
Arena Capital Advisors, LLC- CA 75,000$731,0000.06%
FIR TREE CAPITAL MANAGEMENT LP 150,000$1,449,0000.05%
Athanor Capital, LP 147,800$1,428,0000.05%
Woodline Partners LP 275,000$2,654,0000.05%
Ghisallo Capital Management LLC 125,000$1,208,0000.05%
SUVRETTA CAPITAL MANAGEMENT, LLC 300,000$2,922,0000.04%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders